reference/13611640

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13611640

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	740
issn	1532-6535 0009-9236
issueIdentifier	3
pageRange	733-740
publicationName	Clinical pharmacology and therapeutics
startingPage	733
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_99d0fbf5834a522c04fa4cec947d0f5b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_453c1c34b533fa36a29b65c705176f41 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5c764a198cd326800947813846cab00b
bibliographicCitation	Lu B, Sun L, Seraydarian M, Hoffmann TJ, Medina MW, Risch N, Iribarren C, Krauss RM, Oni‐Orisan A. Effect of SLCO1B1 T521C on Statin‐Related Myotoxicity With Use of Lovastatin and Atorvastatin. Clin Pharma and Therapeutics. 2021 Jul 23;110(3):733–40. doi: 10.1002/cpt.2337.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6893-4449 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a2a08792b09409c706011182cd91623 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43514e65a83412ff76f38faba8224148 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5897-5543 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cc48cd9b8c8e4c8fb4a9a417b498e42 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3631-0129 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82c3afc3837698dbf73c98040d6eb2b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fbd237499c0869fe02f7af174d63e574 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_963083cde6796f1a70ec33ea741ba826
date	2021-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8376784 https://doi.org/10.1002/cpt.2337 https://pubmed.ncbi.nlm.nih.gov/34114646
isPartOf	https://portal.issn.org/resource/ISSN/0009-9236 https://portal.issn.org/resource/ISSN/1532-6535 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3058
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Effect of SLCO1B1 T521C on Statin‐Related Myotoxicity With Use of Lovastatin and Atorvastatin
discusses	http://id.nlm.nih.gov/mesh/M0179294 http://id.nlm.nih.gov/mesh/M0369303 http://id.nlm.nih.gov/mesh/M0012707 http://id.nlm.nih.gov/mesh/M0028567 http://id.nlm.nih.gov/mesh/M0489687
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D019161Q000009 http://id.nlm.nih.gov/mesh/D000069059Q000009 http://id.nlm.nih.gov/mesh/D008148Q000009 http://id.nlm.nih.gov/mesh/D000081030Q000235 http://id.nlm.nih.gov/mesh/D027381Q000235 http://id.nlm.nih.gov/mesh/D000081030Q000209
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000375Q000235 http://id.nlm.nih.gov/mesh/D009135Q000235 http://id.nlm.nih.gov/mesh/D009135Q000139 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D016022 http://id.nlm.nih.gov/mesh/D010641 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D020641Q000235 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8544 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6720 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fa668cfb5a05e25241a052d89a0d398f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9103

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10599

Total number of triples: 66.